Dosage Forms and Drug Carrier Articles from the International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Topic search: DOSAGE FORMS/DRUG CARRIERS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Dosage Forms and Drug Carrier Articles
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Allen Loyd V Jr	Jul/Aug 2024 Pg. 296-297
Compounding and Characterization of a Selfmicroemulsifying System of Ticagrelor Tablets for Enhanced Solubility Kumaravelrajan Rajagopal, Naresh Narayanan, Mohanta Guru Prasad, Venkatesan Suba, Prasad Pasupuleti Dharani	May/Jun 2024 Pg. 194-204
Recommended Tips for Treating Veterinary Patients Bramwell Bethany L, Williams LaVonn A	May/Jun 2024 Pg. 226-227
Carprofen 2.5-mg/mL Oral Suspension, Veterinary Allen Loyd V Jr	May/Jun 2024 Pg. 243
Diltiazem 5% in Lipoderm, Veterinary Allen Loyd V Jr	May/Jun 2024 Pg. 244
Miconazole 1% Ophthalmic Solution, Veterinary Allen Loyd V Jr	May/Jun 2024 Pg. 245
Magic Mouthwashes- A Literature Review and Discussion of Common Compositions McElhiney Linda F	Mar/Apr 2024 Pg. 94-98
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Safe Use of Topical Local Anesthetic Medications for Pain Management Epshteyn Mikhail G, Pepin Steven M	Mar/Apr 2024 Pg. 118-119
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Allen Loyd V Jr	Mar/Apr 2024 Pg. 130
Analgesic Compound Lotion, Clear Allen Loyd V Jr	Mar/Apr 2024 Pg. 132
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Allen Loyd V Jr	Mar/Apr 2024 Pg. 133
Diclofenac Sodium 1% Soft-patch Gel Allen Loyd V Jr	Mar/Apr 2024 Pg. 134
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr	Mar/Apr 2024 Pg. 135
Hydrophilic Ready-to-use Vehicles and Compounded Topical Medications Spennacchio Antonio, Lacassia Chiara, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio	Mar/Apr 2024 Pg. 138-145
Lipophilic Ready-to-use Vehicles and Compounded Topical Medications Lacassia Chiara, Spennacchio Antonio, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio	Mar/Apr 2024 Pg. 146-150
Physical-chemical Stability of the Extemporaneous Paracetamol Oral Suspension in Puccini Base Lacassia Chiara, Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio	Mar/Apr 2024 Pg. 151-155
Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro™ Cream Base, VersaPro™ Gel Base and PLO Gel Mediflo™ 30 Compound Kit Friciu Mihaela, Cull Erica, Haiub Halema, Lupatini Rodrigo, Leclair Grégoire	Mar/Apr 2024 Pg. 156-160
Clinical Safety Profile of TrichoConcept™, a Line of Cosmetic Vehicles for Personalized Treatment of Alopecia Marianni Bruna, Polonini Hudson, Silva Carolina	Mar/Apr 2024 Pg. 169-175
Treatment Options for Male Hypogonadism Biundo Bruce	Jan/Feb 2024 Pg. 6-14
The Physiologic Role and Use of Estriol Paoletti Jim E	Jan/Feb 2024 Pg. 16-21
Hormone Treatment Options for Males: What to do for Men with Low Testosterone Biundo Bruce	Jan/Feb 2024 Pg. 28-32
Estradiol 0.1% Vaginal Solution Allen Loyd V Jr	Jan/Feb 2024 Pg. 58
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Allen Loyd V Jr	Nov/Dec 2023 Pg. 474-481
Calculations Stockton Shelly J	Nov/Dec 2023 Pg. 488
Curcumin 1% Intranasal Mucoadhesive Gel Allen Loyd V Jr	Nov/Dec 2023 Pg. 490
Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base Allen Loyd V Jr	Nov/Dec 2023 Pg. 492
Salicylic Acid 30% Gel Allen Loyd V Jr	Nov/Dec 2023 Pg. 493
Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications Dharmian Jose Prakash, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram	Nov/Dec 2023 Pg. 494-502
Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics Rofiq Hanifah Mohd, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin	Nov/Dec 2023 Pg. 512-521
Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet Hazdi Siti Nursaqifah, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin	Nov/Dec 2023 Pg. 522-527
Compounding Metformin for Use in Functional Medicine Desai Sarina, Thompson Tara	Sep/Oct 2023 Pg. 362-366
Basics of Compounding: Compounding Foams Allen Loyd V Jr	Sep/Oct 2023 Pg. 386-395
Crotamiton 10% Cream Allen Loyd V Jr	Sep/Oct 2023 Pg. 412
Fluconazole 1% Thermoresponsive Gel Allen Loyd V Jr	Sep/Oct 2023 Pg. 414-415
Idoxuridine 5% in Dimethyl Sulfoxide Allen Loyd V Jr	Sep/Oct 2023 Pg. 417
Povidone Iodine Lotion Allen Loyd V Jr	Sep/Oct 2023 Pg. 421
Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X	Sep/Oct 2023 Pg. 424-430
Topical Vehicles: A Dermatologist's Perspective Adame Stephanie, Collins Michael E, Korman Abraham M	Jul/Aug 2023 Pg. 278-283
Chlorhexidine and Cetrimide Lotion Allen Loyd V Jr	Jul/Aug 2023 Pg. 316
Clobazam 5-mg/mL Suspension Allen Loyd V Jr	Jul/Aug 2023 Pg. 317-318
Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream Allen Loyd V Jr	Jul/Aug 2023 Pg. 319
Cyclosporine Topical Gel Formulation Allen Loyd V Jr	Jul/Aug 2023 Pg. 320-321
Levofloxacin 0.5% Topical Gel Allen Loyd V Jr	Jul/Aug 2023 Pg. 324-325
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2023 Pg. 326
Nystatin Oromucosal Gel Allen Loyd V Jr	Jul/Aug 2023 Pg. 327
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip	Jul/Aug 2023 Pg. 340-346
Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds Touprong Robin, Thompson Tara, Williams LaVonn A	May/Jun 2023 Pg. 182-190
Nonsterile Basics of Compounding: Compounding with Humectants Allen Loyd V Jr	May/Jun 2023 Pg. 218-221
Calculations Stockton Shelly J	May/Jun 2023 Pg. 230-231
Acetaminophen 500-mg/mL Rectal Solution Allen Loyd V Jr	May/Jun 2023 Pg. 232-233
Gentamicin 480-mg/1000-mL Bladder Irrigation Allen Loyd V Jr	May/Jun 2023 Pg. 235
Migraine Headache Suppositories Allen Loyd V Jr	May/Jun 2023 Pg. 237
Nifedipine, Lidocaine, and Nitroglycerin Suppositories Allen Loyd V Jr	May/Jun 2023 Pg. 238
An Alternative Approach to Tablet Splitting and Grinding for Medication Administration Taneja Rajneesh, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao	May/Jun 2023 Pg. 240-249
Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base Spennacchio Antonio, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio	May/Jun 2023 Pg. 256-262
PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap! Allen Loyd V Jr	Mar/Apr 2023 Pg. 92
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana	Mar/Apr 2023 Pg. 108-112
Amphotericin B 0.1% Topical Microemulsion Allen Loyd V Jr	Mar/Apr 2023 Pg. 143
Aphthous Ulcer Gel Allen Loyd V Jr	Mar/Apr 2023 Pg. 144
Cyclosporine Topical Microemulsion Allen Loyd V Jr	Mar/Apr 2023 Pg. 146
Hypochlorous Acid 0.01% Oral Rinse Allen Loyd V Jr	Mar/Apr 2023 Pg. 147
Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse Allen Loyd V Jr	Mar/Apr 2023 Pg. 148
Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray Allen Loyd V Jr	Mar/Apr 2023 Pg. 153
Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman	Jan/Feb 2023 Pg. 6-10
Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery Rachmawati Putriana	Jan/Feb 2023 Pg. 24-29
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Allen Loyd V Jr	Jan/Feb 2023 Pg. 30-37
Acetaminophen 10 mg/mL for Rectal Use Allen Loyd V Jr	Jan/Feb 2023 Pg. 50
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 51
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 52
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53
Manning's Liniment Allen Loyd V Jr	Jan/Feb 2023 Pg. 54
Mayer's Ointment Allen Loyd V Jr	Jan/Feb 2023 Pg. 55
Povidone Iodine 100-mg/mL Solution/Spray Allen Loyd V Jr	Jan/Feb 2023 Pg. 56
Psoriasis Topical Ointment Allen Loyd V Jr	Jan/Feb 2023 Pg. 57
Suspension Solution, Sugar Free Allen Loyd V Jr	Jan/Feb 2023 Pg. 58-59
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael	Nov/Dec 2022 Pg. 468-472
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Riepl Mike	Nov/Dec 2022 Pg. 480-488
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Allen Loyd V Jr	Nov/Dec 2022 Pg. 490-495
Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion Allen Loyd V Jr	Nov/Dec 2022 Pg. 508
Curcumin 2% Topical Gel Allen Loyd V Jr	Nov/Dec 2022 Pg. 509
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba	Nov/Dec 2022 Pg. 516-521
PreScription: A New Dosage Form Allen Loyd V Jr	Sep/Oct 2022 Pg. 356
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Ejeta Fikadu	Sep/Oct 2022 Pg. 370-377
Calculations Stockton Shelly J	Sep/Oct 2022 Pg. 420
Amphotericin B 3% Otic Gel Allen Loyd V Jr	Sep/Oct 2022 Pg. 422
Clotrimazole 10-mg Troches Allen Loyd V Jr	Sep/Oct 2022 Pg. 426
Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo	Sep/Oct 2022 Pg. 436-439
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Riepl Mike	Jul/Aug 2022 Pg. 270-274
Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules de Oliveira Ferreira Anderson, Polonini Hudson	Jul/Aug 2022 Pg. 283-291
Basics: Hollow-type Suppositories Allen Loyd V Jr	Jul/Aug 2022 Pg. 302-307
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion Allen Loyd V Jr	Jul/Aug 2022 Pg. 318
Dexamethasone 1 mg/mL in Oral Mix Allen Loyd V Jr	Jul/Aug 2022 Pg. 320
Indomethacin 1% Topical Gel Allen Loyd V Jr	Jul/Aug 2022 Pg. 325-326
Nystatin 250,000-unit Frozen Popsicles Allen Loyd V Jr	Jul/Aug 2022 Pg. 327
Povidone Iodine 100-mg/mL Solution/Spray Allen Loyd V Jr	Jul/Aug 2022 Pg. 328
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando	Jul/Aug 2022 Pg. 330-335
Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude	Jul/Aug 2022 Pg. 336-341
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide Riepl Mike	May/Jun 2022 Pg. 189-193
A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties Mady Omar	May/Jun 2022 Pg. 195-200
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Allen Loyd V Jr	May/Jun 2022 Pg. 214-217
Alendronate Sodium 1% Topical Dental Gel Allen Loyd V Jr	May/Jun 2022 Pg. 232
Azstarys in Ora-Blend Single Dose Allen Loyd V Jr	May/Jun 2022 Pg. 233
Sirolimus 0.1% Ointment Allen Loyd V Jr	May/Jun 2022 Pg. 240
Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam	May/Jun 2022 Pg. 255-263
PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Allen Loyd V Jr	Mar/Apr 2022 Pg. 92
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Riepl Mike	Mar/Apr 2022 Pg. 94-98
The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel	Mar/Apr 2022 Pg. 110-115
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Allen Loyd V Jr	Mar/Apr 2022 Pg. 118-126
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Codeine Phosphate 3 mg/mL in Ora-Sweet Allen Loyd V Jr	Mar/Apr 2022 Pg. 141
Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish Allen Loyd V Jr	Mar/Apr 2022 Pg. 142
Lorazepam 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 143
Mesalamine 100-mg/mL Suspension Enema Allen Loyd V Jr	Mar/Apr 2022 Pg. 144
Naproxen 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 145
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Allen Loyd V Jr	Mar/Apr 2022 Pg. 146
Phenytoin 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 147
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 149
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice	Mar/Apr 2022 Pg. 150-154
Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Mar/Apr 2022 Pg. 155-162
Molding as Innovative Technology for Personalized Tablet Production Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A	Mar/Apr 2022 Pg. 163-174
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez	Jan/Feb 2022 Pg. 6-8
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin Riepl Mike	Jan/Feb 2022 Pg. 18-23
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Allen Loyd V Jr	Jan/Feb 2022 Pg. 34-38
Aluminum Chloride 6.25% in Anhydrous Alcohol Allen Loyd V Jr	Jan/Feb 2022 Pg. 52
Ascorbic Acid 10% in Anhydrous PEG ointment Allen Loyd V Jr	Jan/Feb 2022 Pg. 53
Deoxyarbutin 3% Anhydrous Emulsion Allen Loyd V Jr	Jan/Feb 2022 Pg. 54
Diclofenac Sodium 1%-15% Topical Gel Allen Loyd V Jr	Jan/Feb 2022 Pg. 55
Mometasone Furoate 0.1% Lotion Allen Loyd V Jr	Jan/Feb 2022 Pg. 57
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh	Jan/Feb 2022 Pg. 65-71
Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin A.B.M. Helal, Sarker Zaidul Islam, Bin Liew Kai	Jan/Feb 2022 Pg. 80-87
Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports Agbi Kelechi E, Carvalho Maria, Vieira-Banov Fabiana	Nov/Dec 2021 Pg. 464-467
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin Riepl Mike	Nov/Dec 2021 Pg. 468-472
Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars Harris Kylie, Wright Edward	Nov/Dec 2021 Pg. 482-485
Domperidone 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 500
Kayexalate in Lactulose Allen Loyd V Jr	Nov/Dec 2021 Pg. 501
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 502
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Allen Loyd V Jr	Nov/Dec 2021 Pg. 504
Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 508
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 509
Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim	Nov/Dec 2021 Pg. 523-527
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Uttaro Elizabeth, Zhao Fang, Schweighardt Anne	Sep/Oct 2021 Pg. 364-371
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Riepl Mike	Sep/Oct 2021 Pg. 372-377
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli	Sep/Oct 2021 Pg. 422-426
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio	Sep/Oct 2021 Pg. 427-430
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2 Riepl Mike	Jul/Aug 2021 Pg. 282-287
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Allen Loyd V Jr	Jul/Aug 2021 Pg. 304-309
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Allen Loyd V Jr	Jul/Aug 2021 Pg. 320
Atomoxetine 4-mg/mL Oral Solution/Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 321
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Allen Loyd V Jr	Jul/Aug 2021 Pg. 322
Budesonide 0.0.25% Mucoadhesive Gel Allen Loyd V Jr	Jul/Aug 2021 Pg. 323
Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2021 Pg. 324
Hydrocortisone 2-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 325
Moh's Paste, Modified Allen Loyd V Jr	Jul/Aug 2021 Pg. 326
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Tacrolimus 0.1% Topical Microemulsion Allen Loyd V Jr	Jul/Aug 2021 Pg. 328
Valsartan 4-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2021 Pg. 329
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah	Jul/Aug 2021 Pg. 336-343
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases Teimouri Arezou, Yeung Pollen, Agu Remigius U	Jul/Aug 2021 Pg. 344-351
Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents Allen Loyd V Jr	May/Jun 2021 Pg. 218-221
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia	May/Jun 2021 Pg. 236-240
In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester McKinney Rachael D, Dunbar Jacob R	May/Jun 2021 Pg. 241-245
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report McKettrick Greg, Yoch Doug	Mar/Apr 2021 Pg. 94-98
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing Riepl Mike	Mar/Apr 2021 Pg. 100-103
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants Allen Loyd V Jr	Mar/Apr 2021 Pg. 126-128
Amlodipine 1-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 142
Canine Soft Chew Base (Veterinary) Allen Loyd V Jr	Mar/Apr 2021 Pg. 143
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 144
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2021 Pg. 145
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso	Mar/Apr 2021 Pg. 146-155
Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes Walsh Andrea, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E	Mar/Apr 2021 Pg. 163-168
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A	Mar/Apr 2021 Pg. 169-175
Design and Performance of an Inexpensive Water Activity Meter Gilda Sagar S, Schober Joseph M, McPherson Timothy	Jan/Feb 2021 Pg. 48-51
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Cheung Matthew, Zhao Fang, Dave Vivek S	Jan/Feb 2021 Pg. 82-87
NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Nov/Dec 2020 Pg. 446-448
Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use Teimouri Arezou, Yeung Pollen, Agu Remigius U	Nov/Dec 2020 Pg. 482-490
Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations Kiselova Olga, Maurina Baiba, Sidlovska Venta	Nov/Dec 2020 Pg. 491-500
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Teimouri Arezou, Yeung Pollen, Agu Remigius U	Nov/Dec 2020 Pg. 501-508
Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Nov/Dec 2020 Pg. 509-514
Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L. Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton	Nov/Dec 2020 Pg. 515-518
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott	Nov/Dec 2020 Pg. 519-527
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna	Sep/Oct 2020 Pg. 367-369
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants Allen Loyd V Jr	Sep/Oct 2020 Pg. 388-395
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2020 Pg. 407
Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson	Sep/Oct 2020 Pg. 408-412
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A	Sep/Oct 2020 Pg. 413-419
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2 Riepl Mike	Jul/Aug 2020 Pg. 278-281
Compounding Pearls -- Wound Care: Burn Healing, Part 2 Riepl Mike	Jul/Aug 2020 Pg. 282-285
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Allen Loyd V Jr	Jul/Aug 2020 Pg. 313
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S	Jul/Aug 2020 Pg. 337-345
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1 Riepl Mike	May/Jun 2020 Pg. 182-186
Compounding Pearls -- Wound Care: Burn Healing, Part 1 Riepl Mike	May/Jun 2020 Pg. 188-193
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Hagan John C III, Everett Eric, Chamberlain Tyler	May/Jun 2020 Pg. 194-197
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture Ngim Kenley, Patel Jalpa	May/Jun 2020 Pg. 242-245
Low-dose Pilocarpine Spray to Treat Xerostomia Zur Eyal	Mar/Apr 2020 Pg. 104-108
Calculations Stockton Shelly J	Mar/Apr 2020 Pg. 128
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren	Mar/Apr 2020 Pg. 140-147
Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai	Mar/Apr 2020 Pg. 148-155
Feasibility Study of Asthma Cream Kuang Andrew	Mar/Apr 2020 Pg. 163-167
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard	Mar/Apr 2020 Pg. 168-175
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 57
LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 59
Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives Allen Loyd V Jr	Nov/Dec 2019 Pg. 472-477
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Shakshuki Ayah, Agu Remigius U	Nov/Dec 2019 Pg. 496-503
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Zur Eyal	Sep/Oct 2019 Pg. 366-375
Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Zur Eyal	Sep/Oct 2019 Pg. 376-381
Basics: Excipients Used in Nonsterile Compounding, Part 2 Allen Loyd V Jr	Sep/Oct 2019 Pg. 393-396
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Allen Loyd V Jr	Sep/Oct 2019 Pg. 399-402
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2 Zur Eyal	Jul/Aug 2019 Pg. 288-293
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy Glaser Rebecca L, York Anne E	Jul/Aug 2019 Pg. 325-339
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing Allen Loyd V Jr	May/Jun 2019 Pg. 211-216
Trends of Extemporaneous Drug Prescription in Latvia in 2017 Kiselova Olga, Maurina Baiba, Sidlovska Venta, Rogovska Irena	May/Jun 2019 Pg. 245-249
Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation Rashid Mamoon, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy	May/Jun 2019 Pg. 250-257
Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Zur Eyal	Mar/Apr 2019 Pg. 94-104
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Zur Eyal	Mar/Apr 2019 Pg. 113-119
Dexamethasone 2 mg/g Topical Paste, Veterinary Allen Loyd V Jr	Mar/Apr 2019 Pg. 149
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Mar/Apr 2019 Pg. 150
Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Zur Eyal	Jan/Feb 2019 Pg. 23-31
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Jan/Feb 2019 Pg. 52
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Allen Loyd V Jr	Jan/Feb 2019 Pg. 54
Orodispersible Film Allen Loyd V Jr	Jan/Feb 2019 Pg. 59
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson	Jan/Feb 2019 Pg. 65-69
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C	Jan/Feb 2019 Pg. 77-81
Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream Shakshuki Ayah, Agu Remigius U	Jan/Feb 2019 Pg. 82-87
Case Study: Absorption of Testosterone Cream via Scrotal Delivery Needham Shawn, Needham Shane	Nov/Dec 2018 Pg. 466-468
Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review Cutaia Kara, Chablani Lipika, Zhao Fang	Nov/Dec 2018 Pg. 480-489
Calculations Stockton Shelly J	Nov/Dec 2018 Pg. 490
Compounded Orodispersible Films with Natural Ingredients for Halitosis: A Clinical Experience Apolinário Régis De Souza, Chaves Maria Das Graças Afonso Miranda, Gonçalves Hanny Reis Mockdeci, Martins Isadora Conde Ferreria, De Paula Renée Mazilão, Granato Ana Paula Alves, Polonini Hudson Caetano, Brandão Marcos Antônio Fernandes, Ferreira Anderson De Oliveira, Raposo Nádia Rezende Barbosa	Nov/Dec 2018 Pg. 512-515
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Cysteamine 0.5% Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2018 Pg. 408
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	Sep/Oct 2018 Pg. 409
Stability of Tranexamic Acid Mouth Rinse Donnelly Ronald F	Sep/Oct 2018 Pg. 412-416
Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 Allen Loyd V Jr	Jul/Aug 2018 Pg. 294-300
Anhydrous Medium-chain Triglycerides Gel Allen Loyd V Jr	Jul/Aug 2018 Pg. 316
Budesonide 1-mg//10-mL Mucolox Oral Suspensions Allen Loyd V Jr	Jul/Aug 2018 Pg. 317
Pitch Ointment: Applications in Scar and Wound Management Kloesel Lawson, Carvalho Maria, Banov Fabiana	May/Jun 2018 Pg. 182-188
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications Agbi Kelechi E, Hover Sara, Carvalho Maria	May/Jun 2018 Pg. 196-202
Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1 Allen Loyd V Jr	May/Jun 2018 Pg. 220-228
Calculations Stockton Shelly J	May/Jun 2018 Pg. 230
Anhydrous Silicon Base Topical Gel Vehicle Allen Loyd V Jr	May/Jun 2018 Pg. 232
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 235
Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 236
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Allen Loyd V Jr	May/Jun 2018 Pg. 237
Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 238
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 239
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun	Mar/Apr 2018 Pg. 108-121
Basics of Compounding: Compounding Microemulsions Allen Loyd V Jr	Mar/Apr 2018 Pg. 137-143
Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini	Mar/Apr 2018 Pg. 154-163
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H	Mar/Apr 2018 Pg. 172-175
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Kosinski Tracy M, Brown Michael C, Zavala Pedro J	Jan/Feb 2018 Pg. 41-46
Calculations Stockton Shelly J	Jan/Feb 2018 Pg. 48
Sodium Citrate 9% Nasal Spray for Olfactory Disorders Allen Loyd V Jr	Jan/Feb 2018 Pg. 57
Feline Transdermal Formulation Considerations Forsythe Lauren Eichstadt	Nov/Dec 2017 Pg. 446-452
Orodispersible Films for Compounding Pharmacies Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa	Nov/Dec 2017 Pg. 454-461
Basics of Compounding: Hot Melt Extrusion DePasquale Seth	Nov/Dec 2017 Pg. 471-479
Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 490
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Chuong Monica C, Taglieri Catherine A, Kerr Stephen G	Nov/Dec 2017 Pg. 500-512
Validation of the Technological Process of the Preparation "Milk by Vidal" Savchenko LP, Mishchenko VA, Georgiyants VA	Nov/Dec 2017 Pg. 513-517
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing Allen Loyd V Jr	Sep/Oct 2017 Pg. 388-392
Acetylcysteine Solutions for Inhalation Allen Loyd V Jr	Sep/Oct 2017 Pg. 408
Tacrolimus 0.3-mg/mL Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2017 Pg. 416
Vancomycin 50 mg/mL in Oral Syrup Suspension Allen Loyd V Jr	Sep/Oct 2017 Pg. 417
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N	Sep/Oct 2017 Pg. 418-425
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Choo Winnie	Jul/Aug 2017 Pg. 282-289
Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future Allen Loyd V Jr	Jul/Aug 2017 Pg. 293-298
Basics of Sterile Compounding: Excipients Used in Injections Akers Michael J	Jul/Aug 2017 Pg. 301-308
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream Allen Loyd V Jr	Jul/Aug 2017 Pg. 312
Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel Allen Loyd V Jr	Jul/Aug 2017 Pg. 313
Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel Allen Loyd V Jr	Jul/Aug 2017 Pg. 314
Ferrous Sulfate 30-mg Fe/mL Oral Drops Allen Loyd V Jr	Jul/Aug 2017 Pg. 316
Tacrolimus 0.06% Ophthalmic Drops Allen Loyd V Jr	Jul/Aug 2017 Pg. 319
Tranilast 8% Pluronic Lecithin Organogel Gel Allen Loyd V Jr	Jul/Aug 2017 Pg. 321
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine	Jul/Aug 2017 Pg. 347-351
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Jones Nat, Carvalho Maria, Branvold-Herr Andrea	May/Jun 2017 Pg. 205-211
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2 Allen Loyd V Jr	May/Jun 2017 Pg. 215-220
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E	May/Jun 2017 Pg. 242-246
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students Benischek Rita	Mar/Apr 2017 Pg. 105-108
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Allen Loyd V Jr	Mar/Apr 2017 Pg. 127-130
Accuracy Considerations in Sterile Compounding Akers Michael J	Mar/Apr 2017 Pg. 133-142
Calculations Stockton Shelly J	Mar/Apr 2017 Pg. 144
Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date Gautam Pradeep, Light Bob, Purvis Troy	Mar/Apr 2017 Pg. 154-159
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J	Mar/Apr 2017 Pg. 164-170
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson	Mar/Apr 2017 Pg. 171-175
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane	Jan/Feb 2017 Pg. 22-27
Analytic Methods Used in Quality Control in a Compounding Pharmacy Allen Loyd V Jr	Jan/Feb 2017 Pg. 31-37
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Akers Michael J	Jan/Feb 2017 Pg. 47-56
Nifedipine 0.5% Rectal Ointment Allen Loyd V Jr	Jan/Feb 2017 Pg. 63
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding Rush Steven D, Vernak Charlene, Zhao Fang	Jan/Feb 2017 Pg. 83-87
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey	Nov/Dec 2016 Pg. 461-467
Basics of Compounding: Clinical Pharmaceutics, Part 2 Allen Loyd V Jr	Nov/Dec 2016 Pg. 485-493
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr	Nov/Dec 2016 Pg. 495-500
Calculations Stockton Shelly J	Nov/Dec 2016 Pg. 502
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Allen Loyd V Jr	Nov/Dec 2016 Pg. 507
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle	Nov/Dec 2016 Pg. 517-520
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H	Nov/Dec 2016 Pg. 521-525
Basics of Compounding: Clinical Pharmaceutics, Part 1 Allen Loyd V Jr	Sep/Oct 2016 Pg. 389-396
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Allen Loyd V Jr	Sep/Oct 2016 Pg. 407
Naproxen 5% Cream Allen Loyd V Jr	Sep/Oct 2016 Pg. 410
Permethrin 1% Lotion Allen Loyd V Jr	Sep/Oct 2016 Pg. 411
Progesterone 10% Cream Allen Loyd V Jr	Sep/Oct 2016 Pg. 412
Tetracaine Hydrochloride 2% Topical Solution Allen Loyd V Jr	Sep/Oct 2016 Pg. 414
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Tannous Elias, Tal Yana, Amarny Kamal	Sep/Oct 2016 Pg. 438-439
Compounding Transdermal Medication for Feline Patients Eichstadt Lauren R	Jul/Aug 2016 Pg. 271-274
Basics of Compounding: Compounding Films Allen Loyd V Jr	Jul/Aug 2016 Pg. 298-305
Calculations Stockton Shelly J	Jul/Aug 2016 Pg. 316-317
Gatifloxacin 0.5% Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 319
Neomycin Sulfate 25-mg/mL Oral Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 321
Nystatin 100,000-units Vaginal Inserts Allen Loyd V Jr	Jul/Aug 2016 Pg. 322
1,2-Octanediol 5% Topical Liquid Allen Loyd V Jr	Jul/Aug 2016 Pg. 323
Phytonadione 1-mg/mL Oral Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 324
Plasmingen and Hyaluronate Sodium Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 325
Scopolamine Hydrobromide 0.25% Ophthalmic Solution Allen Loyd V Jr	Jul/Aug 2016 Pg. 326
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M	Jul/Aug 2016 Pg. 347-350
Basics of Compounding: Special Capsules Allen Loyd V Jr	May/Jun 2016 Pg. 209-214
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Allen Loyd V Jr	May/Jun 2016 Pg. 228
Dexpanthenol 5% Nasal Spray Allen Loyd V Jr	May/Jun 2016 Pg. 229
Indomethacin Gel Allen Loyd V Jr	May/Jun 2016 Pg. 230
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr	May/Jun 2016 Pg. 231
Montelukast Sodium 5-mg Fast-Dissolving Film Allen Loyd V Jr	May/Jun 2016 Pg. 232
Pain-Away II Headache Capsules Allen Loyd V Jr	May/Jun 2016 Pg. 233
Topical Metered-dosing Dispenser Performance Evaluation Liu Qiang, Kupiec Thomas C, Vu Nicole T	May/Jun 2016 Pg. 239-246
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Trimble John, Light Bob	May/Jun 2016 Pg. 250-256
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Basics of Compounding: Capsules Allen Loyd V Jr	Mar/Apr 2016 Pg. 125-134
Formulation and Stability of Solutions Akers Michael J	Mar/Apr 2016 Pg. 137-141
Calculations Stockton Shelly J	Mar/Apr 2016 Pg. 142
Blue Goo Anti-Itch Gel Allen Loyd V Jr	Mar/Apr 2016 Pg. 144
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Allen Loyd V Jr	Mar/Apr 2016 Pg. 145
Medicated Polyox Bandage for Skin Ulcers Allen Loyd V Jr	Mar/Apr 2016 Pg. 146
Utilization of Compounded Medications in an Oral Medicine Practice Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel	Mar/Apr 2016 Pg. 155-158
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy	Mar/Apr 2016 Pg. 159-163
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Nahata Milap C	Mar/Apr 2016 Pg. 164-166
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Choo Winnie	Jan/Feb 2016 Pg. 6-10
Basic Principles of Lyophilization, Part 2 Akers Michael J	Jan/Feb 2016 Pg. 20-27
Formulation and Stability of Solutions Akers Michael J	Jan/Feb 2016 Pg. 41-45
Aprepitant 80-mg Capsules Allen Loyd V Jr	Jan/Feb 2016 Pg. 48
Aripiprazole 10-mg Oral Dissolving Tablets Allen Loyd V Jr	Jan/Feb 2016 Pg. 49
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Allen Loyd V Jr	Jan/Feb 2016 Pg. 50
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Allen Loyd V Jr	Jan/Feb 2016 Pg. 51
Mupirocin Calcium 2% Cream Allen Loyd V Jr	Jan/Feb 2016 Pg. 52
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Allen Loyd V Jr	Jan/Feb 2016 Pg. 53
Thrombin 1,000 Units/mL Topical Solution, Sterile Allen Loyd V Jr	Jan/Feb 2016 Pg. 54
Tropicamide 1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2016 Pg. 55
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B	Jan/Feb 2016 Pg. 71-80
Mixing in a Compounding Pharmacy in the 21st Century Standridge Rob	Nov/Dec 2015 Pg. 479-484
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr	Nov/Dec 2015 Pg. 508
Mupirocin 2% Nasal Ointment Allen Loyd V Jr	Nov/Dec 2015 Pg. 512
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin	Sep/Oct 2015 Pg. 357-365
Aminocaproic Acid 250-mg/mL Oral Solution Allen Loyd V Jr	Sep/Oct 2015 Pg. 404
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Allen Loyd V Jr	Sep/Oct 2015 Pg. 405
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Allen Loyd V Jr	Sep/Oct 2015 Pg. 406
Nimodipine 3-mg/mL Oral Solution Allen Loyd V Jr	Sep/Oct 2015 Pg. 407
Ofloxacin 0.3% Otic Solution Allen Loyd V Jr	Sep/Oct 2015 Pg. 408
Povidone Iodine 10% Cold Sore Paint Allen Loyd V Jr	Sep/Oct 2015 Pg. 409
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Allen Loyd V Jr	Sep/Oct 2015 Pg. 410
Vehicle for Oral Solution (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 411
Vehicle for Oral Solution, Sugar Free (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 412
Vehicle for Oral Suspension (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 413
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa	Sep/Oct 2015 Pg. 414-419
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures Nahata Milap C	Sep/Oct 2015 Pg. 428-431
Balsam Peru, Castor Oil, and Trypsin Ointment Allen Loyd V	Jul/Aug 2015 Pg. 325
Proparacaine Hydrochloride 0.5% Ophthalmic Solution Allen Loyd V	Jul/Aug 2015 Pg. 332
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Guth Michael AS	May/Jun 2015 Pg. 195-203
Basics of Compounding: Compounding with Silicones Allen Loyd V Jr	May/Jun 2015 Pg. 223-230
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Allen Loyd V Jr	May/Jun 2015 Pg. 243
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Allen Loyd V Jr	May/Jun 2015 Pg. 244
Stability of Metronidazole Suspensions Donnelly Ronald F, Ying James	May/Jun 2015 Pg. 248-251
Protocol of Blood Serum Eye Drops Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos	May/Jun 2015 Pg. 252-260
Heparin 335-United/Gram Gel-Cream Allen Loyd V Jr	Mar/Apr 2015 Pg. 145
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Allen Loyd V Jr	Mar/Apr 2015 Pg. 148
Transdermal Delivery of Nisoldipine: Refinement of Vehicles El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A	Mar/Apr 2015 Pg. 152-160
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott	Mar/Apr 2015 Pg. 161-166
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott	Mar/Apr 2015 Pg. 167-173
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jan/Feb 2015 Pg. 6-12
Lidocaine Hydrochloride 4% Topical Solution Allen Loyd V Jr	Jan/Feb 2015 Pg. 67
Mupirocin 2% Ointment Allen Loyd V Jr	Jan/Feb 2015 Pg. 68
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J	Jan/Feb 2015 Pg. 70-72
Stability of Suspensions: Theoretical and Practical Considerations before Compounding Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina	Jan/Feb 2015 Pg. 78-85
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula Sherr Zachary, Karara Adel H	Nov/Dec 2014 Pg. 462-468
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Akers Michael J	Nov/Dec 2014 Pg. 479-484
Calculations Stockton Shelly J	Nov/Dec 2014 Pg. 492-493
Skin Penetration and Antinociception of Topical Gabapentin Formulations Bryson Evan, Asbill Scott, Sweitzer Sarah	Nov/Dec 2014 Pg. 504-511
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Heustess Allie, Asbill Scott, Eagerton David, Arnold John	Nov/Dec 2014 Pg. 512-515
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils Boonme Prapaporn, Maneenuan Duangkhae	Nov/Dec 2014 Pg. 516-519
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy	Nov/Dec 2014 Pg. 520-525
PreScription: What is a Compounding Pharmacist? Allen Loyd V Jr	Sep/Oct 2014 Pg. 356
To Compound or Not to Compound: A Veterinary Transdermal Discussion Eichstadt Lauren R, Davidson Gigi S	Sep/Oct 2014 Pg. 366-369
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari	Sep/Oct 2014 Pg. 370-377
Bacitracin Topical Ointment Allen Loyd V Jr	Sep/Oct 2014 Pg. 409
Sulfamethoxazole and Trimethoprim Oral Solution Allen Loyd V Jr	Sep/Oct 2014 Pg. 415
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis Reisacher William, Rudner Shara, Kotik Viktoriya	Jul/Aug 2014 Pg. 287-290
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Vu Nicole, Lou Jessica R, Kupiec Thomas C	Jul/Aug 2014 Pg. 305-310
Basics of Compounding Sterile Preparations: Nomenclature and Considerations Allen Loyd V Jr	Jul/Aug 2014 Pg. 313-317
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Allen Loyd V Jr	Jul/Aug 2014 Pg. 318-319
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B	Jul/Aug 2014 Pg. 332-340
Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding Hoffmann Brittany, Carlson Christie, Rao Deepa A	Jul/Aug 2014 Pg. 341-344
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Peacock Gina F, Sauvageot Jurgita	Jul/Aug 2014 Pg. 345-347
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Peacock Gina F, Sauvageot Jurgita, Addo Richard T	Jul/Aug 2014 Pg. 348-350
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Warner Meredith, Tuder Dmitry	May/Jun 2014 Pg. 182-188
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice McNulty John P, Muller George	May/Jun 2014 Pg. 190-200
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1 Vu Nicole, Lou Jessica R, Kupiec Thomas	May/Jun 2014 Pg. 213-221
Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams Allen Loyd V Jr	May/Jun 2014 Pg. 228-230
Butorphanol Tartrate 10-mg/mL Nasal Spray Allen Loyd V Jr	May/Jun 2014 Pg. 235
Dibucaine 1% Ointment Allen Loyd V Jr	May/Jun 2014 Pg. 236
Investigation of Physical and Chemical Stability of an Ointment with Herbals Zdoryk Oleksandr A, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I	May/Jun 2014 Pg. 248-252
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth	May/Jun 2014 Pg. 256-261
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Vu Nicole, Nguyen Devin, Kupiec Thomas C	Mar/Apr 2014 Pg. 123-130
Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions Allen Loyd V Jr	Mar/Apr 2014 Pg. 137-138
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Zur Eyal	Jan/Feb 2014 Pg. 14-19
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks Allen Loyd V Jr	Jan/Feb 2014 Pg. 42-45
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study Ruiz Andres D, Daniels Kelly R	Jan/Feb 2014 Pg. 70-77
Basics of Compounding: Basics of Compounding with Balsams Allen Loyd V Jr	Nov/Dec 2013 Pg. 490-495
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie	Nov/Dec 2013 Pg. 512-514
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Wang Xuexuan, Black Laura	Nov/Dec 2013 Pg. 520-525
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms McElhiney Linda F	Sep/Oct 2013 Pg. 364-368
Chemical Penetration Enhancers Newton Stephen J	Sep/Oct 2013 Pg. 370-374
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease McElhiney Linda F	Sep/Oct 2013 Pg. 380-383
Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Pruitt Bobby N III	Sep/Oct 2013 Pg. 384-387
Calculations Stockton Shelly J, Saluja Hardeep Singh	Sep/Oct 2013 Pg. 412
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny	Sep/Oct 2013 Pg. 424-431
Basics of Compounding: Foam Dosage Forms Allen Loyd V Jr	Jul/Aug 2013 Pg. 312-322
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs Boonme Prapaporn, Maneenuan Duangkhae, Channarong Sunee	Jul/Aug 2013 Pg. 347-350
Optimizing Third-party Reimbursement for Compounded Medications McElhiney Linda F	May/Jun 2013 Pg. 201-204
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott	May/Jun 2013 Pg. 247-253
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Klemmer Anja, Krämer Irene, Kamin Wolfgang	May/Jun 2013 Pg. 254-261
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Zur Eyal	Mar/Apr 2013 Pg. 113-123
Stability of Minoxidil in Espumil Foam Base Geiger Christine M, Sorenson Bridget, Whaley Paul A	Mar/Apr 2013 Pg. 165-167
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Zur Eyal	Jan/Feb 2013 Pg. 10-22
Treatment Options for Male Hypogonadism Biundo Bruce	Jan/Feb 2013 Pg. 28-38
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Zur Eyal	Nov/Dec 2012 Pg. 462-469
Colds and Cough Allen Loyd V Jr	Nov/Dec 2012 Pg. 480-483
Stability of Ursodiol in SyrSpend SF Cherry Flavored Geiger Christine M, Voudrie Mark A II, Sorenson Bridget	Nov/Dec 2012 Pg. 510-512
Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations Ammar Hussein O, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M	Nov/Dec 2012 Pg. 516-523
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Zur Eyal	Sep/Oct 2012 Pg. 386-393
Calculations Stockton Shelly J	Sep/Oct 2012 Pg. 416
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Peacock Gina F, Sauvageot Jurgita	Sep/Oct 2012 Pg. 428-430
Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Radojkovic Branko, Milic Jela, Calija Bojan	Sep/Oct 2012 Pg. 434-437
A Concise Discussion of Headache Types, Part 3: Migraine Williams LaVonn A, Allen Loyd V Jr	Jul/Aug 2012 Pg. 270-274
Burning Mouth Syndrome: A Discussion of a Complex Pathology Zur Eyal	May/Jun 2012 Pg. 196-205
Treatment and Prevention of Insect Bites: Mosquitoes Williams LaVonn A, Allen Loyd V Jr	May/Jun 2012 Pg. 210-218
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Lehman Paul A, Raney Sam G	May/Jun 2012 Pg. 248-252
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Griffee Chris, Delano Amy	Mar/Apr 2012 Pg. 110-114
Chemical Stability of Pentoxifylline in a Topical Cream Gupta Vishnu D	Jan/Feb 2012 Pg. 80-81
Vitamins: Therapy or Hype Wynn Tom, Hoffrogge Zach	Jan/Feb 2012 Pg. 17-21
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Bramwell Bethany L, Williams LaVonn A	Jan/Feb 2012 Pg. 62-63
Compounding for Treatment of Equine Infectious Diseases: An Overview Bramwell Bethany L	Nov/Dec 2011 Pg. 450-457
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Zur Eyal	Nov/Dec 2011 Pg. 458-463
Diaper Rash Relief: Common Sense Remedies and Treatments Wiliams Kacee D, Williams LaVonn	Nov/Dec 2011 Pg. 464-469
Calculations Stockton Shelly J	Nov/Dec 2011 Pg. 498
Cefepime 1% Ophthalmic Solution Allen Loyd V Jr	Nov/Dec 2011 Pg. 500
Citric Acid 3% Mouthrinse Solution Allen Loyd V Jr	Nov/Dec 2011 Pg. 501
Dapsone 5% Topical Gel Allen Loyd V Jr	Nov/Dec 2011 Pg. 502
Lavender Oil 4% in Polyethylene Glycol Ointment Allen Loyd V Jr	Nov/Dec 2011 Pg. 503
Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution Allen Loyd V Jr	Nov/Dec 2011 Pg. 507
Vancomycin 31-mg/mL Ophthalmic Solution Allen Loyd V Jr	Nov/Dec 2011 Pg. 508
Vancomycin 2% in Silver Sulfadiazine Cream Allen Loyd V Jr	Nov/Dec 2011 Pg. 509
A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard Walker Heather, Sridhar Vishak, Alexander Kenneth S	Nov/Dec 2011 Pg. 510-514
Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant Jha Antesh Kr, Chetia D	Nov/Dec 2011 Pg. 521-525
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions McElhiney Linda F	Sep/Oct 2011 Pg. 376-380
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient McElhiney Linda F	Sep/Oct 2011 Pg. 386-387
Carvedilol 0.625-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 418
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 419
Lorazepam 1-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 420
Metoprolol Tartrate 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 421
Nifedipine 1-mg/500-mg Oral Powder Allen Loyd V Jr	Sep/Oct 2011 Pg. 422
Nifedipine 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 423
Rebamipide Rectal Enema Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 424
Sotalol 5-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 425
Sulfadiazine 100-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 426
Ursodiol 50-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 427
Transdermals: The Skin as Part of a Drug Delivery System Allen Loyd V Jr	Jul/Aug 2011 Pg. 308-315
Magnesium Sulfate Paste Allen Loyd V Jr	Jul/Aug 2011 Pg. 339
Treating Inner Ear Disorders with Intratympanic Drug Administration McElhiney Linda F	Jul/Aug 2011 Pg. 302-307
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient McElhiney Linda F	May/Jun 2011 Pg. 194-199
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Wynn Tom, Goetsch Daniel	May/Jun 2011 Pg. 200-203
Treatment Options for Psoriasis Williams LaVonn A, Humphreys Erica	May/Jun 2011 Pg. 204-213
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Allen Loyd V Jr	May/Jun 2011 Pg. 242
Diclofenac Sodium 1% Topical Gel Allen Loyd V Jr	May/Jun 2011 Pg. 243
Ibuprofen 5% Topical Cream Allen Loyd V Jr	May/Jun 2011 Pg. 244
Sport Body Cooler Allen Loyd V Jr	May/Jun 2011 Pg. 247
Tannic Acid 5% Alcohol Gel Allen Loyd V Jr	May/Jun 2011 Pg. 248
Triamcinolone 0.1% Lotion Allen Loyd V Jr	May/Jun 2011 Pg. 249
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Allen Loyd V Jr	May/Jun 2011 Pg. 245
Triclosan 2% Topical Cream Allen Loyd V Jr	May/Jun 2011 Pg. 250
Wound Cleaner Solution Allen Loyd V Jr	May/Jun 2011 Pg. 251
Testosterone Levels in an Aging Population: Screen, Measure, and Restore Kells John, DollbaumCharles M	Mar/Apr 2011 Pg. 102-112
Mandl's Paint Allen Loyd V Jr	Mar/Apr 2011 Pg. 162
Oral Film Strip Vehicle Allen Loyd V Jr	Mar/Apr 2011 Pg. 164
Tea Tree Oil Acne Gel Allen Loyd V Jr	Mar/Apr 2011 Pg. 165
Nifedpine in Compounded Oral and Topical Preparations McCluskey Susan V, Brunn Gregory J	Mar/Apr 2011 Pg. 166-169
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine Bramwell Bethany L	Mar/Apr 2011 Pg. 174-175
Current Concepts in the Treatment of Recurrent Aphthous Ulcers Bramwell Bethany L, Williams LaVonn A	Jan/Feb 2011 Pg. 13-18
Goliath: Case Report on a Canine Case of Epilepsy Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr	Jan/Feb 2011 Pg. 27-31
Toxicities Associated with Topical Anesthetics Bramwell Bethany L	Jan/Feb 2011 Pg. 41
Diclofenac Sodium 10-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2011 Pg. 64
Hydrocortisone Acetate 1% Gel, Alcohol-Free Allen Loyd V Jr	Jan/Feb 2011 Pg. 65
Ibuprofen 5% Gel Allen Loyd V Jr	Jan/Feb 2011 Pg. 66
Mandelic Acid 5% Cream Allen Loyd V Jr	Jan/Feb 2011 Pg. 67
Methotrexate 30-mg/g Topical Gel Allen Loyd V Jr	Jan/Feb 2011 Pg. 68
Piroxicam 1% Gel Allen Loyd V Jr	Jan/Feb 2011 Pg. 69
Pramoxine 1% Cream Allen Loyd V Jr	Jan/Feb 2011 Pg. 70
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture Allen Loyd V Jr	Jan/Feb 2011 Pg. 71
Terbenafine Hydrochloride Bilayer Nail Lacquer Allen Loyd V Jr	Jan/Feb 2011 Pg. 72
Vancomycin Hydrochloride 25-mg/mL Solution Allen Loyd V Jr	Jan/Feb 2011 Pg. 73
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei	Jan/Feb 2011 Pg. 74-77
All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding Williams KaCee D	Nov/Dec 2010 Pg. 484-486
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Rudner Shara, Browne Paul	Nov/Dec 2010 Pg. 488-491
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 512
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 513
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 514
Capsaicin 0.05% Clear Medication Stick Allen Loyd V Jr	Nov/Dec 2010 Pg. 517
Glutathione 25% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 518
Gramicidin 13% Ophthalmic Solution Allen Loyd V Jr	Nov/Dec 2010 Pg. 519
Ketoprofen 2% Oral Gel Allen Loyd V Jr	Nov/Dec 2010 Pg. 521
Extemporaneous Compounding of Medicated Ointment Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana	Nov/Dec 2010 Pg. 472-478
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care Cox Chris	Nov/Dec 2010 Pg. 480-483
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Allen Loyd V Jr	Nov/Dec 2010 Pg. 520
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Pignato Alyssa, Pankaskie Marvin, Birnie Christine	Nov/Dec 2010 Pg. 522-525
Bioidentical Hormones in the News Bramwell Bethany L	Sep/Oct 2010 Pg. 374-380
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients Muller George, Case Tyler, Deen Griffin L	Sep/Oct 2010 Pg. 395-399
Alpha-Bisabolol Mouthwash Allen Loyd V Jr	Sep/Oct 2010 Pg. 420
Icy Blue Camphorated Gel Allen Loyd V Jr	Sep/Oct 2010 Pg. 422
Carvedilol 1-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2010 Pg. 423
Buspirone 2.5-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2010 Pg. 424
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2010 Pg. 421
Triclosan 0.28% Mouthwash Allen Loyd V Jr	Sep/Oct 2010 Pg. 425
Rufinamide 40-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2010 Pg. 426
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Allen Loyd V Jr	Sep/Oct 2010 Pg. 427
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Allen Loyd V Jr	Sep/Oct 2010 Pg. 428
Polidocanol 0.5% Wound Spray Allen Loyd V Jr	Sep/Oct 2010 Pg. 429
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together McElhiney Linda F	Jul/Aug 2010 Pg. 270-274
Recommendations for Compounding Medications for Feeding Tube Administration Klang Mark	Jul/Aug 2010 Pg. 276-282
Considerations for Percutaneous Absorption Newton Stephen J, Cook Jennifer M	Jul/Aug 2010 Pg. 301-304
Amitriptyline Hydrochloride Suppositories Allen Loyd V Jr	Jul/Aug 2010 Pg. 334
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Christiansen Joel, White Lyndell	Jul/Aug 2010 Pg. 310-314
Basics of Compounding: Basics of Compounding with Organic Salts Allen Loyd V Jr	Jul/Aug 2010 Pg. 322-326
Ampicillin 250-mg Suppository Allen Loyd V Jr	Jul/Aug 2010 Pg. 335
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops Allen Loyd V Jr	Jul/Aug 2010 Pg. 336
Flurbiprofen 5% Bioadhesive Gel for Gingivitis Allen Loyd V Jr	Jul/Aug 2010 Pg. 341
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Tong Henry H Y, Chan Hokman, Du Zhen, Zheng Ying	Jul/Aug 2010 Pg. 342-345
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Managing Pain with Transdermal Ketoprofen Williams KaCee D	May/Jun 2010 Pg. 204-206
Potential Treatments for Radiation Dermatitis Corsini Lindsay	May/Jun 2010 Pg. 210-213
Calculations Stockton Shelly J	May/Jun 2010 Pg. 230
Bacitracin 10,000-Units/mL Ophthalmic Solution Allen Loyd V Jr	May/Jun 2010 Pg. 240
Carprofen 2.5-mg/mL Oral Suspension, Veterinary Allen Loyd V Jr	May/Jun 2010 Pg. 241
Celecoxib 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 242
Clozapine 20-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 243
Cohen's Rectal Ointment Allen Loyd V Jr	May/Jun 2010 Pg. 244
Cyclophosphamide 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 245
Lansoprazole 3-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 246
Rifaximin 20-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 247
Sunitinib 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 248
Voriconazole 40-mg/mL Oral Suspension, Veterinary Allen Loyd V Jr	May/Jun 2010 Pg. 249
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne	May/Jun 2010 Pg. 250-256
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient McElhiney Linda F	Mar/Apr 2010 Pg. 112-115
Acyclovir 5% in Oral Adhesive Paste Allen Loyd V Jr	Mar/Apr 2010 Pg. 150
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) Allen Loyd V Jr	Mar/Apr 2010 Pg. 151
Ciclopirox 10% in Isopropyl Alcohol Nail Solution Allen Loyd V Jr	Mar/Apr 2010 Pg. 152
Clotrimazole 1% Oral Adhesive Paste Allen Loyd V Jr	Mar/Apr 2010 Pg. 153
Cyclosporin 10-mg/g in Oral Adhesive Paste Allen Loyd V Jr	Mar/Apr 2010 Pg. 154
Dexpanthenol 5% Gel-Cream Allen Loyd V Jr	Mar/Apr 2010 Pg. 155
Plasticized Hydrocarbon Gel Allen Loyd V Jr	Mar/Apr 2010 Pg. 158
Oral Adhesive Paste Allen Loyd V Jr	Mar/Apr 2010 Pg. 159
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara	Jan/Feb 2010 Pg. 21-25
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R	Jan/Feb 2010 Pg. 40-45
Ketoprofen 100-mg/5-mL Mouth Rinse Allen Loyd V Jr	Jan/Feb 2010 Pg. 68
Metronidazole in Normal Saline Enema Allen Loyd V Jr	Jan/Feb 2010 Pg. 69
Ophthalmic Toning-Lubricating Drops Allen Loyd V Jr	Jan/Feb 2010 Pg. 70
Testosterone 1% in Alcoholic Gel Allen Loyd V Jr	Jan/Feb 2010 Pg. 72
Tetracaine 4% and Menthol 5% Topical Gel Allen Loyd V Jr	Jan/Feb 2010 Pg. 73
Trigger Point Gel Allen Loyd V Jr	Jan/Feb 2010 Pg. 75
When Traditional Medicine Fails Bash Robert	Jan/Feb 2010 Pg. 6-8
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2010 Pg. 74
Cidofovir 0.2-mg/mL Intravitreous Injection Allen Loyd V Jr	Nov/Dec 2009 Pg. 554
Fluconazole 2% Topical Microemulsion Allen Loyd V Jr	Nov/Dec 2009 Pg. 555
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole	Nov/Dec 2009 Pg. 540-543
Ichthammol 10% Otic Solution Allen Loyd V Jr	Nov/Dec 2009 Pg. 557
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Arnold John J, Asbill Scott	Nov/Dec 2009 Pg. 569-571
Lubow's Solution Allen Loyd V Jr	Nov/Dec 2009 Pg. 558
Miconazole 1% Ophthalmic Solution, Veterinary Allen Loyd V Jr	Nov/Dec 2009 Pg. 559
Topiramate 6-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2009 Pg. 560
Twevan Cream Allen Loyd V Jr	Nov/Dec 2009 Pg. 561
Voriconazole 2% Ophthalmic Solution Allen Loyd V Jr	Nov/Dec 2009 Pg. 562
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Bailey Caroline, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole	Nov/Dec 2009 Pg. 564-568
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Parish Roy C	Nov/Dec 2009 Pg. 572-573
Transdermal Dosing Considerations for Veterinarians Williams KaCee D	Sep/Oct 2009 Pg. 358-360
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Williams LaVonn A, Riley Kari	Sep/Oct 2009 Pg. 367-371
Recommended Tips for Treating Veterinary Patients Bramwell Bethany L, Williams LaVonn A	Sep/Oct 2009 Pg. 390-391
Aceclofenac 1.5% Pluronic Lecithin Organogel Allen Loyd V Jr	Sep/Oct 2009 Pg. 428
Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis Allen Loyd V Jr	Sep/Oct 2009 Pg. 432
Lidocaine 10% Oral Pluronic Lecithin Organogel Allen Loyd V Jr	Sep/Oct 2009 Pg. 433
Mechlorethamine Hydrochloride 0.02% Topical Allen Loyd V Jr	Sep/Oct 2009 Pg. 434
Myristyl Nicotinate 5% Topical Gel Allen Loyd V Jr	Sep/Oct 2009 Pg. 435
Nitroglycerin 4-mg Suppository Allen Loyd V Jr	Sep/Oct 2009 Pg. 436
Chemical Stability of Scopolamine Hydrobromide Nasal Solution Gupta Vishnu D	Sep/Oct 2009 Pg. 438-439
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel	Jul/Aug 2009 Pg. 314-317
Moxifloxacin 20-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2009 Pg. 337
Mupirocin 1% (20-mg) Vaginal Suppository Allen Loyd V Jr	Jul/Aug 2009 Pg. 338
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Allen Loyd V Jr	Jul/Aug 2009 Pg. 340
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison Chauhan Harsh, Atef Eman	Jul/Aug 2009 Pg. 342-344
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia Spark M Joy, Dunn Rebecca A, Houlahan Kelli L	Jul/Aug 2009 Pg. 345-349
The Physiologic Role and Use of Estriol Paoletti Jim E	Jul/Aug 2009 Pg. 270-275
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone Biundo Bruce	Jul/Aug 2009 Pg. 276-279
Alcohol-based Carbomer Gel Allen Loyd V Jr	Jul/Aug 2009 Pg. 332
Benzoyl Peroxide 10% Gel Allen Loyd V Jr	Jul/Aug 2009 Pg. 333
Clindamycin 100-mg Vaginal Suppositories Allen Loyd V Jr	Jul/Aug 2009 Pg. 334
Dexamethasone and Furosemide Injection Allen Loyd V Jr	Jul/Aug 2009 Pg. 335
Formulation Optimization Study for an Immediate-Release Tablet Kyriacos Soula, Dimassi Hani	May/Jun 2009 Pg. 259-261
Update on Managing Neuropathic Pain McNulty Jack P, Muller George	May/Jun 2009 Pg. 182-190
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids Zur Eyal	May/Jun 2009 Pg. 192-195
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report Muller George, Hall Linda A, Stovall Audrey, Peters Susan H, Vail Jane	May/Jun 2009 Pg. 196-213
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers Young Jennifer L, Bogner Robin H	May/Jun 2009 Pg. 214-217
Safe Use of Topical Local Anesthetic Medications for Pain Management Epshteyn Mikhail G, Pepin Steven M	May/Jun 2009 Pg. 218-219
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Muller George	May/Jun 2009 Pg. 220-221
Analgesic Compound Lotion, Clear Allen Loyd V Jr	May/Jun 2009 Pg. 240
Hydromorphone Hydrochloride 10-mg/mL Oral Drops Allen Loyd V Jr	May/Jun 2009 Pg. 241
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese	May/Jun 2009 Pg. 250-253
Stability of Pergolide Mesylate Oral Liquid at Room Temperature Shank Brandon R, Ofner Clyde M III	May/Jun 2009 Pg. 254-258
Lidocaine 2% Popsicle Allen Loyd V Jr	May/Jun 2009 Pg. 242
Morphine Sulfate 10-mg/mL Oral Solution Allen Loyd V Jr	May/Jun 2009 Pg. 243
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	May/Jun 2009 Pg. 244
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	May/Jun 2009 Pg. 245
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules Allen Loyd V Jr	May/Jun 2009 Pg. 246
Oxycodone Hydrochloride 20-mg Suppository Allen Loyd V Jr	May/Jun 2009 Pg. 247
Promethazine 20-mg and Acetaminophen 325-mg Suppositories Allen Loyd V Jr	May/Jun 2009 Pg. 248
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules Allen Loyd V Jr	May/Jun 2009 Pg. 249
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule Haywood Alison, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross	Mar/Apr 2009 Pg. 170-174
Aprepitant 20-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2009 Pg. 153
Chloroquine Phosphate 64.5-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2009 Pg. 154
Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation Allen Loyd V Jr	Mar/Apr 2009 Pg. 155
Ionic Hydration Solution for Anti-Cancer Therapy Allen Loyd V Jr	Mar/Apr 2009 Pg. 156
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection Allen Loyd V Jr	Mar/Apr 2009 Pg. 157
Nicotine Rectal Enema Allen Loyd V Jr	Mar/Apr 2009 Pg. 158
Thiothixene Hydrochloride 2-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2009 Pg. 159
Tolterodine 2-mg/5-mL Oral Suspension Allen Loyd V Jr	Mar/Apr 2009 Pg. 160
Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection Allen Loyd V Jr	Mar/Apr 2009 Pg. 161
Compounding for Pediatric Patients: Case Reports and Formulations Mixon William, Angelle Patricea, Yoch Douglas	Jan/Feb 2009 Pg. 6-12
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George	Jan/Feb 2009 Pg. 14-18
Compounding with Sucralfate for the Treatment of External Wounds Wynn Tom, Williams LaVonn A	Jan/Feb 2009 Pg. 25-29
Identifying the Criteria of a Valid Stability Study Williams LaVonn A, Hastings Mitchell Blaine	Jan/Feb 2009 Pg. 32-36
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets Allen Loyd V Jr	Jan/Feb 2009 Pg. 64
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder Allen Loyd V Jr	Jan/Feb 2009 Pg. 65
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel Allen Loyd V Jr	Jan/Feb 2009 Pg. 66
Dextromethorphan Hydrobromide 30-mg Troches Allen Loyd V Jr	Jan/Feb 2009 Pg. 67
Diaper Rash Cream with Miconazole Allen Loyd V Jr	Jan/Feb 2009 Pg. 68
Diphenhydramine Hydrochloride 25-mg Gelatin Troches Allen Loyd V Jr	Jan/Feb 2009 Pg. 69
Electrolyte Lollipop (Adult) Allen Loyd V Jr	Jan/Feb 2009 Pg. 70
Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse Allen Loyd V Jr	Jan/Feb 2009 Pg. 71
Peruvian Balsam, Zinc Stearate, Boric Acid, and Talcum Powder Allen Loyd V Jr	Jan/Feb 2009 Pg. 72
Tetracaine 0.025% Popsicles Allen Loyd V Jr	Jan/Feb 2009 Pg. 73
Testing of Estradiol in a Compounded Cream and a Stock Solution Buderer Matthew J, Buderer Nancy M	Jan/Feb 2009 Pg. 74-77
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Mixon William, Helms Scott R	Sep/Oct 2008 Pg. 392-397
Aceclofenac 1.5% Gel-Cream Allen Loyd V Jr	Sep/Oct 2008 Pg. 446
Acetaminophen 10-mg/mL Rectal Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 447
Dichlorobenzyl Alcohol Tooth Gel Allen Loyd V Jr	Sep/Oct 2008 Pg. 449
Estradiol 0.1% Vaginal Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 450
Flurandrenolide Topical Film Allen Loyd V Jr	Sep/Oct 2008 Pg. 451
Ketoprofen 20% Topical Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 452
Lidocaine Adhesive System Gel Allen Loyd V Jr	Sep/Oct 2008 Pg. 453
Piroxicam 5% and Dexpanthenol 5% Gel Allen Loyd V Jr	Sep/Oct 2008 Pg. 454
Propafenone 1.5-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2008 Pg. 455
Compounding Challenges for Immunocompromised Patients McElhiney Linda F	Nov/Dec 2008 Pg. 482-487
Case Reports: Compounding to Relieve Arthritis Pain Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane	Nov/Dec 2008 Pg. 498-504
Indomethacin 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2008 Pg. 543
Ketorolac Tromethamine 2% Topical Gel Allen Loyd V Jr	Nov/Dec 2008 Pg. 544
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Allen Loyd V Jr	Nov/Dec 2008 Pg. 546
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2008 Pg. 540
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Allen Loyd V Jr	Nov/Dec 2008 Pg. 541
Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches Allen Loyd V Jr	Nov/Dec 2008 Pg. 549
Zirconium Oxide Lotion Allen Loyd V Jr	Jul/Aug 2008 Pg. 364
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise	Jul/Aug 2008 Pg. 365-367
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Gupta Vishnu D	Jul/Aug 2008 Pg. 372-374
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol	Jul/Aug 2008 Pg. 295-304
Quality-Control Analytical Methods: Homogeneity of Dosing Forms Kupiec Thomas C, Vu Nicole, Branscum David	Jul/Aug 2008 Pg. 340-343
Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder Allen Loyd V Jr	Jul/Aug 2008 Pg. 355
Silicone Cream Allen Loyd V Jr	Jul/Aug 2008 Pg. 356
Sodium Chloride 0.9% Ointment Allen Loyd V Jr	Jul/Aug 2008 Pg. 357
Squalene 0.2% Cream Allen Loyd V Jr	Jul/Aug 2008 Pg. 358
Sucralfate and Hyaluronic Acid Ointment Allen Loyd V Jr	Jul/Aug 2008 Pg. 359
Tretinoin and (-)Alpha-Bisabolol Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 360
Tretinoin and Dexpanthenol Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 361
Ultrasonic Adhesive Gel Allen Loyd V Jr	Jul/Aug 2008 Pg. 362
Vitamin A Suppository Allen Loyd V Jr	Jul/Aug 2008 Pg. 363
African Scalp Lotion Allen Loyd V Jr	May/Jun 2008 Pg. 260
Benzyl Benzoate Lotion Allen Loyd V Jr	May/Jun 2008 Pg. 261
Calcium Gluconate 2.5% Topical Gel Allen Loyd V Jr	May/Jun 2008 Pg. 262
Lubricating Gel Allen Loyd V Jr	May/Jun 2008 Pg. 263
Meloxicam 0.3% Topical Gel Allen Loyd V Jr	May/Jun 2008 Pg. 264
Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm Allen Loyd V Jr	May/Jun 2008 Pg. 265
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel Allen Loyd V Jr	May/Jun 2008 Pg. 266
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution Allen Loyd V Jr	May/Jun 2008 Pg. 267
Tolnaftate 1% Antifungal Microemulsion Allen Loyd V Jr	May/Jun 2008 Pg. 268
Valsartan 4-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2008 Pg. 269
Topical Treatment of Neuropathic Pain Vadaurri Vince	May/Jun 2008 Pg. 182-190
Compounded Local Anesthetics to Minimize Pain from Medical Procedures McElhiney Linda F	May/Jun 2008 Pg. 192-197
Dilution and Compounding of Ziconotide for Intrathecal Administration Buchta Tony, Fakata Keri, Stuart William	May/Jun 2008 Pg. 200-207
Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model Bassani August S, Banov Daniel, Lehman Paul A	May/Jun 2008 Pg. 270-273
Acyclovir 5% Topical Ointment Allen Loyd V Jr	Mar/Apr 2008 Pg. 146
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting de Oliveira Ferreira Anderson, Holandino Carla	Mar/Apr 2008 Pg. 163-169
Alum 6.5% Topical Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 147
Aminacrine Hydrochloride 0.1% Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 148
Butesin Picrate 1% ointment Allen Loyd V Jr	Mar/Apr 2008 Pg. 149
Carbamazepine Topical Preparations Allen Loyd V Jr	Mar/Apr 2008 Pg. 150
Chlorhexidine Gel Allen Loyd V Jr	Mar/Apr 2008 Pg. 151
EDTA 1% Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 152
Erythromycin 1% and Neomycin Sulfate Ointment Allen Loyd V Jr	Mar/Apr 2008 Pg. 153
Heparin Gel-Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 154
Hydrogen Peroxide 8% Cream Allen Loyd V Jr	Mar/Apr 2008 Pg. 155
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Dib Jean G, Abdulmohsin Saud	Jan/Feb 2008 Pg. 8-14
Cyclosporine Topical Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 64
Diclofenac Sodium 1% Soft-Patch Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 65
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 66
Diltiazem 5% in Lipoderm, Veterinary Allen Loyd V Jr	Jan/Feb 2008 Pg. 67
Emetine Hydrochloride 30-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2008 Pg. 68
Flosulide 10-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2008 Pg. 69
Pentoxifylline 20-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2008 Pg. 70
Piroxicam 1% Soft-Patch Lipophilic Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 71
Piroxicam 1% Soft-Patch Topical Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 72
Trimethoprim 10-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2008 Pg. 73
Aloe Vera Gel Allen Loyd V Jr	Nov/Dec 2007 Pg. 504
Breast Care Cream Allen Loyd V Jr	Nov/Dec 2007 Pg. 505
Castor Oil and Trypsin Ointment Allen Loyd V Jr	Nov/Dec 2007 Pg. 506
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Zugerman Jessie Jean M, Reed Thomas C	Nov/Dec 2007 Pg. 514-519
Chlorhexidine 2% Gel Allen Loyd V Jr	Nov/Dec 2007 Pg. 507
Coal Tar 2% and Allantoin 2.5% Cream Allen Loyd V Jr	Nov/Dec 2007 Pg. 508
Foscarnet 2.5% Topical Cream Allen Loyd V Jr	Nov/Dec 2007 Pg. 509
Interferon alfa-2b Ophthalmic Solution Allen Loyd V Jr	Nov/Dec 2007 Pg. 510
Miconazole 2% Oral Gel Allen Loyd V Jr	Nov/Dec 2007 Pg. 512
Rabbit Medicine Jordan Dinah G	Sep/Oct 2007 Pg. 364-374
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs Allen Loyd V Jr	Sep/Oct 2007 Pg. 416
Betamethasone Valerate 0.1% Topical Gel Allen Loyd V Jr	Sep/Oct 2007 Pg. 419
Dexpanthenol 5% Gel-Cream Allen Loyd V Jr	Sep/Oct 2007 Pg. 420
Diclofenac Sodium 75-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2007 Pg. 421
Hydrocortisone 0.5% Ethanolic Gel Allen Loyd V Jr	Sep/Oct 2007 Pg. 423
Neomycin 0.05% Topical Gel Allen Loyd V Jr	Sep/Oct 2007 Pg. 424
Isoniazid Release from Suppositories Compounded with Selected Bases Hudson Kristofer C, Asbill C Scott, Webster Andrew A	Sep/Oct 2007 Pg. 433-437
Ketoconazole 25-mg Liquid Suppository Allen Loyd V Jr	Jul/Aug 2007 Pg. 329
Mebeverine Hydrochloride 20% gel Allen Loyd V Jr	Jul/Aug 2007 Pg. 330
Oseltamivir 12-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2007 Pg. 332
Phenytoin Sodium 20-mg/mL Topical Suspension Allen Loyd V Jr	Jul/Aug 2007 Pg. 333
Vehicle N Formulas Allen Loyd V Jr	Jul/Aug 2007 Pg. 337
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	May/Jun 2007 Pg. 220-225
Calculations - Compounding for Pain Management Stockton Shelly J	May/Jun 2007 Pg. 238-239
Benazepril 2-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 242
Cholecalciferol 40,000-IU/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 243
Folic Acid 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 244
Glycopyrrolate 0.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 245
Isoproterenol Compound Elixir Allen Loyd V Jr	May/Jun 2007 Pg. 246
Levothyroxine Sodium 40-micro-g/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 247
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 248
Methylphenidate 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 249
Thiamine Hydrochloride 100-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 250
Trovafloxacin Mesylate 10-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 251
Transdermal Gel in the Treatment of Postoperative Pain Alexander Kayla, Wynn Tom	May/Jun 2007 Pg. 181-184
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited Vail Jane	May/Jun 2007 Pg. 187-192
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids Vail Jane	May/Jun 2007 Pg. 194-199
Insulins: Historical and Current Perspectives Vance Dwight A	Mar/Apr 2007 Pg. 95-104
Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh Vail Jane	Mar/Apr 2007 Pg. 106-110
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes Fields Shannon W	Mar/Apr 2007 Pg. 122-124
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster Fields Shannon W	Mar/Apr 2007 Pg. 131
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms Vu Nicole	Mar/Apr 2007 Pg. 145-148
Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh Vail Jane	Mar/Apr 2007 Pg. 132-135
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	Jan/Feb 2007 Pg. 5-8
Pediatric Oral Formulations: A Continual Challenge Hurtado Josephine, Moffett Brady S	Jan/Feb 2007 Pg. 17-19
Case Report: Treatment of Labial Adhesions in a Child Fields Shannon W	Jan/Feb 2007 Pg. 27
Caffeine Citrate 10-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 69
Carbidopa 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 71
Dexamethasone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 72
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 73
Lansoprazole 3-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 74
Methyldopa 25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 75
Metolazone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 76
Chemical Stability of Desonide in Ear Drops Gupta Vishnu D	Jan/Feb 2007 Pg. 79-81
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Benischek Rita L	Nov/Dec 2006 Pg. 428-433
Ronidazole in the Treatment of Trichomonad Infections in Cats Davidson Gigi S	Nov/Dec 2006 Pg. 434-435
Chloral Hydrate 50-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 453
Cyclophosphamide 2-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 454
Disulfiram 25-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 455
Gabapentin 100-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 456
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 457
Indomethacin 2-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 458
Naltrexone 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 459
Terbutaline Sulfate 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 460
Valacyclovir 50-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 461
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations Piette Marie, Stassen Thibaut, Kinget Renaat, Delattre Luc	Nov/Dec 2006 Pg. 469-477
Compounding for Feline Herpetic Keratitis Davidson Gigi S	Nov/Dec 2006 Pg. 411-414
Compounding for Veterinary Medicine Fields Shannon W	Nov/Dec 2006 Pg. 417-418
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety Fields Shannon W	Nov/Dec 2006 Pg. 418
Taurine for the Treatment of Canine Dilated Cardiomyopathy Vail Jane	Nov/Dec 2006 Pg. 421-424
Amiloride Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 452
Topical Cidofovir for Treatment of Resistant Viral Infections McElhiney Linda F	Sep/Oct 2006 Pg. 324-328
Dermatological Effects from Years in the Sun: Compounding Opportunities Jones Marty	Sep/Oct 2006 Pg. 336-342
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches Williams Steve D	Sep/Oct 2006 Pg. 351
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Bigeleisen Paul E	Sep/Oct 2006 Pg. 392-395
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Trissel Lawrence A, Zhang Yanping, Koontz Susannah E	Sep/Oct 2006 Pg. 396-399
Compounded Treatment Options for Cystitis and Other Bladder Problems McElhiney Linda F	Jul/Aug 2006 Pg. 270-275
Hospice Symptom Relief Kit: An Update Petrin Ronald L	Jul/Aug 2006 Pg. 288-290
Adderall 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 299
Dapsone 2-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 300
Itraconazole 40-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 301
Lisinopril 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 302
Nifedipine 4-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 303
Propranolol Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 304
Sildenafil Citrate 2.5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 306
Tramadol Hydrochloride 5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 307
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 308
Stability of Memantine in an Extemporaneously Prepared Oral Liquid Yamreudeewong Weeranuj, Teixeira M Glaucia, Mayer Gabriele E	Jul/Aug 2006 Pg. 316-317
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Reed-Kane Dana, Kirshbaum Karen	May/Jun 2006 Pg. 165-171
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Tran Tuan, Kupiec Thomas C, Trissel Lawrence A	May/Jun 2006 Pg. 202-204
Basics of Compounding for Dentistry, Part 2: Tooth Whitening Fonseca Simonne C	May/Jun 2006 Pg. 205-207
Triamcinolone Acetonide 0.1% Mouthwash Solution Allen Loyd V Jr	May/Jun 2006 Pg. 229
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn	Mar/Apr 2006 Pg. 147-153
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Moon Richard B	Mar/Apr 2006 Pg. 95-98
Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations Fonseca Simonne C	Mar/Apr 2006 Pg. 122-127
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh Vail Jane	Jan/Feb 2006 Pg. 9-11
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery Heim Bob	Jan/Feb 2006 Pg. 14-18 View Sample
Chlorambucil 2-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 59
Dantrolene Sodium 5-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 60
Domperidone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 61
Efavirenz 20-mg/mL Oral Liquid, Anhydrous Allen Loyd V Jr	Jan/Feb 2006 Pg. 62
Medium-Chain Triglycerides Oral Vehicle, Anhydrous Allen Loyd V Jr	Jan/Feb 2006 Pg. 63
Mercaptopurine 50-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 64
Misoprostol 1-mg Suppository Allen Loyd V Jr	Jan/Feb 2006 Pg. 65
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 66
Propylthiouracil 5-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 67
Thioguanine 40-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 68
Prescription: Pediatric Formulation Initiatives Allen Loyd V Jr	Nov/Dec 2005 Pg. 410
Unlocking Autism: Is Compounding the Key? Vail Jane	Nov/Dec 2005 Pg. 413-420
Compounding for a Pediatric Hospital McElhiney Linda F	Nov/Dec 2005 Pg. 423-431
Wiping Out Diaper Rash Fields Shannon W	Nov/Dec 2005 Pg. 433-434 View Sample
Pediatric Oral Liquid Preparations Fonseca Simonne C, Ferreira Anderson de O	Nov/Dec 2005 Pg. 437-442
Alprazolam 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 472
Bethanechol 5-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 473
Clonazepam 0.1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 474
Dolasetron 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 475
Ganciclovir 100-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 476
Isradipine 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 477
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Fonseca Simonne C	Nov/Dec 2005 Pg. 456-461
Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products Allen Loyd V Jr	Nov/Dec 2005 Pg. 462-469
Pyrazinamide 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 478
Quinidine Sulfate 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 479
Ursodiol 25-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 480
Valganciclovir Hydrochloride 60-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 481
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Gupta Vishnu D	Nov/Dec 2005 Pg. 484-486
A Patient's Guide to Transdermal Treatment of Pain Fields Shannon W	Sep/Oct 2005 Pg. 354
Update on Transdermals for Animal Patients Davidson Gigi S	May/Jun 2005 Pg. 178-182 View Sample
Basics of Compounding for Hair Care -- Part 2: Medicated Conditions Fonseca Simonne C	May/Jun 2005 Pg. 215-218
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D	May/Jun 2005 Pg. 242-246
Return to Top